Phospho-specific Smad3 signaling: impact on breast oncogenesis

Related Experiment Video

Updated: May 21, 2026

Exploring the Pharmacological Action and Molecular Mechanism of Salidroside in Inhibiting MCF-7 Cell Proliferation and Migration
11:13

Exploring the Pharmacological Action and Molecular Mechanism of Salidroside in Inhibiting MCF-7 Cell Proliferation and Migration

Published on: June 9, 2023

Elizabeth Tarasewicz1, Jacqueline S Jeruss

  • 1Department of Surgery, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.

Cell Cycle (Georgetown, Tex.)
|June 5, 2012
PubMed

Insights

Transforming growth factor beta (TGFβ) signaling has a dual role in breast cancer. Phospho-specific Smad3, a key mediator, shows critical roles in malignancy with potential prognostic and therapeutic impacts.

Area of Science:

  • Molecular Biology
  • Oncology
  • Cell Signaling

Background:

  • Transforming growth factor beta (TGFβ) superfamily influences mammary gland development and cancer.
  • TGFβ signaling exhibits dichotomous roles in breast cancer, inhibiting growth but promoting epithelial-mesenchymal transition (EMT) in cancer cells.
  • Mechanisms underlying TGFβ's switch in breast cancer are under active investigation.

Purpose of the Study:

  • To review recent advances in understanding the role of Smad3 phosphorylation in breast cancer.
  • To highlight the significance of phospho-specific Smad3 isoforms in malignancy.
  • To illustrate the potential prognostic and therapeutic implications of Smad3 phospho-isoforms.

Main Methods:

  • Literature review of recent studies on TGFβ signaling and Smad3.
  • Analysis of research on Smad3 phosphorylation sites and their functional consequences.
  • Synthesis of findings related to Smad3 phospho-isoforms in breast cancer progression.

Main Results:

  • Smad3 is a crucial intracellular mediator of TGFβ signaling, regulated by phosphorylation.
  • Multiple kinases phosphorylate Smad3 at various sites, adding complexity to TGFβ signaling.
  • Phospho-specific Smad3 isoforms play a critical role in breast cancer malignancy.

Conclusions:

  • Understanding Smad3 phosphorylation is key to deciphering TGFβ's complex role in breast cancer.
  • Phospho-Smad3 isoforms represent potential biomarkers for prognosis in breast cancer.
  • Targeting Smad3 phospho-isoforms may offer novel therapeutic strategies for breast cancer treatment.

More Related Videos

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells06:54

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells

Published on: October 27, 2020

Spheroid Assay to Measure TGF-β-induced Invasion09:18

Spheroid Assay to Measure TGF-β-induced Invasion

Published on: November 16, 2011

Related Concept Videos

TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...